A Randomised, Double-Blind, French Multi-Centre Study, to Evaluate the Efficacy and Tolerance, in Comparison With Placebo, of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults.
Phase of Trial: Phase III
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Triamcinolone (Primary)
- Indications Rhinitis
- Focus Therapeutic Use
- Acronyms RhiCNANI
- Sponsors Sanofi
- 22 Oct 2008 Actual patient number (77) added as reported by ClinicalTrials.gov.
- 22 Oct 2008 Planned end date changed from 1 Aug 2007 to 1 Apr 2007.as reported by ClinicalTrials.gov.
- 05 Jul 2007 New trial record.